Clinical Trials Sponsored by Allergopharma GmbH & Co. KG

Total 256 results

Allergopharma GmbH & Co. KG

Completed

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

Allergic Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Allergic Asthma | Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative

Allergic Rhinoconjunctivitis

Sweden
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

Birch Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Grass Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture

Grass Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Efficacy and Safety of a Purified Standardised Bee Venom Preparation

Bee Venom Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Multicenter Trial of Immunotherapy With House Dust Mite Allergoid (ACRI)

Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma

Respiratory Hypersensitivity

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens

Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis

Allergic Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Efficacy and Safety From a Recombinant Folding Variant of Bet v 1

Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation (ALLEGRA6)

Allergy | Rhinitis | Conjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

Type I Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma (AMETHYST)

Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Type I-Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

Birch Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Open Label Safety Study of a Birch Pollen Allergen Extract

Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

House Dust Mite Allergy

Germany
Allergopharma GmbH & Co. KG
Inflamax Research Incorporated

Terminated

Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

Healthy Volunteers | Allergic Rhinoconjunctivitis

Canada
Medical University of Lodz
Allergopharma GmbH & Co. KG

Completed

Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy

Seasonal Allergic Rhinitis

Poland
Johann Wolfgang Goethe University Hospital
Allergopharma GmbH & Co. KG

Completed

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

Immunotherapy

Germany
RHEACELL GmbH & Co. KG

Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Epidermolysis Bullosa

Austria
Oryx GmbH & Co. KG

Completed

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme. (ParvOryx01)

Glioblastoma Multiforme

Germany
Seca GmbH & Co. Kg.

Completed

Generation of Prediction Equations for BIA of the Elderly

Healthy Elderly

Germany
photonamic GmbH & Co. KG

Completed

5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities

Actinic Keratoses

Germany
Apceth GmbH & Co. KG

Terminated

Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101 (TREAT-ME 1)

Advanced Gastrointestinal Cancer

Germany
Cytonet GmbH & Co. KG

Completed

Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders

Ornithine Transcarbamylase Deficiency | Urea Cycle Disorders | Citrullinemia | Carbamoylphosphate Synthetase I Deficiency

Germany
Seca GmbH & Co. Kg.

Completed

Generation of Normal Ranges to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA)

Healthy

Germany
Seca GmbH & Co. Kg.

Completed

Detection of Patients With Abnormal Water Distribution Based on Bioelectrical Impedance Analysis (BIA)

Kidney Diseases

Germany
Seca GmbH & Co. Kg.

Completed

Generation of Prediction Equations to Analyze Body Composition of Adults Based on Bioelectrical Impedance Analysis (BIA)

Bioelectrical Impedance Measurement of Healthy Adults

Germany
Cytonet GmbH & Co. KG

Completed

Study to Evaluate 13 C Isotope Ratio Measurement for Urea Cycle Capacity Assessment

Urea Cycle Disorders

Germany
photonamic GmbH & Co. KG

Recruiting

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Glioblastoma

Germany
Oryx GmbH & Co. KG

Completed

Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer (ParvOryx02)

Carcinoma, Pancreatic Ductal

Germany
Seca GmbH & Co. Kg.

Completed

Generation of Prediction Equations to Analyze Body Composition of Obese Adults Based on BIA

Bioelectrical Impedance Measurement of Healthy Adults

Germany
photonamic GmbH & Co. KG

Terminated

Fluorescence-guided Resection in Breast Cancer

Breast Tumour

Germany
photonamic GmbH & Co. KG

Completed

Photodynamic Therapy of Actinic Keratoses With Alacare®

Actinic Keratosis

Germany
Apceth GmbH & Co. KG

Completed

Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia

Peripheral Artery Disease | Critical Limb Ischemia

Germany
Oryx GmbH & Co. KG

Completed

Vaccination Against MSI Colorectal Cancer

Colorectal Cancer

Germany
Vygon GmbH & Co. KG

Unknown

Prospective Trial of the Bilevel Positive Airway Pressure (by Boussignac) in Emergency Department of Non-invasive Patients Presenting With Acute Hypercapnic Respiratory Failure (Boussignac)

Acute-on-chronic Respiratory Failure

Germany
Vitacare Gmbh & Co. KG

Completed

Acid Lactase in Combination With Yoghurt Bacteria for Improvement of Lactose Digestion in Lactose Malabsorbers

Lactose Malabsorption

Germany
photonamic GmbH & Co. KG

Completed

PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK

Actinic Keratosis

Germany
RHEACELL GmbH & Co. KG

Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

Epidermolysis Bullosa

United States
Seca GmbH & Co. Kg.

Completed

Comparing Medical Body Composition Analyzer Seca mBCA 555 With Seca mBCA 515

Bioelectrical Impedance Measurement of Healthy Adults

Germany
photonamic GmbH & Co. KG

Completed

Evaluation of the Suitability of PD P 506 A in the PDT of Distal Subungual Onychomycosis (DSO) of the Great Toenail.

Onychomycosis

Germany
Oryx GmbH & Co. KG

Completed

Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers (VICORYX-2)

HPV-induced Cancers

Germany
Cytonet GmbH & Co. KG

Terminated

Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders

Urea Cycle Disorders

United States, Canada
Oryx GmbH & Co. KG

Completed

Immune Therapy of HPV-induced Cancers

HPV-induced Cancers

Germany

3

Subscribe